Camp4 Therapeutics (CAMP) FCF Margin (2024 - 2026)

Camp4 Therapeutics has reported FCF Margin for 3 years, with the latest figure at 848.61% in Q1 2026.

• Quarterly FCF Margin rose 81643.0% year-over-year to 848.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 674.3% (up 257040.0% YoY) and the FY2025 annual result came in at 852.83%, up 620284.0% from the prior year.
• FCF Margin slipped to 848.61% in Q1 2026 per CAMP's latest filing, from 1795.11% in the prior quarter.
• Over five years, FCF Margin peaked at 1795.11% in Q4 2025 and troughed at 1771.63% in Q4 2024.
• A 3-year average of 767.48% and a median of 1126.88% in 2025 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2025 and 2026: FCF Margin soared 356674 bps in 2025, then jumped 81643 bps in 2026.
• Over 3 years, FCF Margin stood at 1771.63% in 2024, then soared by 201 bps to 1795.11% in 2025, then plunged by 147 bps to 848.61% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 848.61%, 1795.11%, and 1405.16% for Q1 2026, Q4 2025, and Q3 2025 respectively.